1. Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens. Issue 1 (31st December 2022) Authors: Jiang, Hu-Dachuan; Guo, Xi-ling; Jin, Peng-Fei; Tang, Rong; Li, Jing-Xin; Zhu, Feng-Cai Journal: Emerging microbes & infections Issue: Volume 11:Issue 1(2022) Page Start: 1751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 10249 (15th August 2020) Authors: Zhu, Feng-Cai; Guan, Xu-Hua; Li, Yu-Hua; Huang, Jian-Ying; Jiang, Tao; Hou, Li-Hua; Li, Jing-Xin; Yang, Bei-Fang; Wang, Ling; Wang, Wen-Juan; Wu, Shi-Po; Wang, Zhao; Wu, Xiao-Hong; Xu, Jun-Jie; Zhang, Zhe; Jia, Si-Yue; Wang, Bu-Sen; Hu, Yi; Liu, Jing-Jing; Zhang, Jun Journal: Lancet Issue: Volume 396:Issue 10249(2020) Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Next Steps for Efficacy Evaluation in Clinical Trials of COVID-19 Vaccines. (July 2021) Authors: Jiang, Hu-Dachuan; Zhang, Li; Li, Jing-Xin; Zhu, Feng-Cai Journal: Engineering Issue: Volume 7:Number 7(2021) Page Start: 903 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Issue 10240 (13th June 2020) Authors: Zhu, Feng-Cai; Li, Yu-Hua; Guan, Xu-Hua; Hou, Li-Hua; Wang, Wen-Juan; Li, Jing-Xin; Wu, Shi-Po; Wang, Bu-Sen; Wang, Zhao; Wang, Lei; Jia, Si-Yue; Jiang, Hu-Dachuan; Wang, Ling; Jiang, Tao; Hu, Yi; Gou, Jin-Bo; Xu, Sha-Bei; Xu, Jun-Jie; Wang, Xue-Wen; Wang, Wei Journal: Lancet Issue: Volume 395:Issue 10240(2020) Page Start: 1845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗